Engaging patients in discussions about different phosphate binders and their unique characteristics is key to improving adherence and satisfaction. New therapies that reduce pill size or burden while ...

2,4 For people with type 2 diabetes, CKD can be a significant burden and can cause additional sickness, including increased risk of cardiovascular problems and death," it added. The US FDA ...

The community is coming together to support Captain Shawn Waguespack, a longtime volunteer officer with the Lafourche Parish Sheriff’s Department Reserve Division, as he prepares for a life-saving ...

Climate change is increasing the risk of urological diseases, including cancer and kidney conditions, while urological ...

If approved, we look forward to offering OLC to CKD patients on dialysis with hyperphosphatemia ... Dialysis patients often face a high daily pill burden, with phosphate binders making up ...

Therefore, the identification of the risk factors for CKD and the corresponding preventing strategies are essential to alleviate the disease burden.” The hazard ratio for current smoking status ...

New therapies that reduce pill size or burden while maintaining efficacy ... treatment of hyperphosphatemia in patients with chronic kidney disease (CKD). OLC has over forty issued and granted ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RA) significantly reduce the risk for clinically meaningful chronic kidney disease (CKD) progression and major adverse cardiovascular events (MACE) in ...